AVITA Medical Statistics Share Statistics AVITA Medical has 26.64M
shares outstanding. The number of shares has increased by 1.6%
in one year.
Shares Outstanding 26.64M Shares Change (YoY) 1.6% Shares Change (QoQ) 0.77% Owned by Institutions (%) 27.22% Shares Floating 26.06M Failed to Deliver (FTD) Shares 9,670 FTD / Avg. Volume 1.46%
Short Selling Information The latest short interest is 4.53M, so 16.77% of the outstanding
shares have been sold short.
Short Interest 4.53M Short % of Shares Out 16.77% Short % of Float 16.9% Short Ratio (days to cover) 2.11
Valuation Ratios The PE ratio is -5.36 and the forward
PE ratio is -7.
AVITA Medical's PEG ratio is
-0.08.
PE Ratio -5.36 Forward PE -7 PS Ratio 5.16 Forward PS 1.4 PB Ratio 73.64 P/FCF Ratio -5.69 PEG Ratio -0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AVITA Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.83,
with a Debt / Equity ratio of 10.22.
Current Ratio 2.83 Quick Ratio 2.47 Debt / Equity 10.22 Debt / EBITDA -0.83 Debt / FCF -0.79 Interest Coverage -10.56
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $247.12K Profits Per Employee $-237.87K Employee Count 260 Asset Turnover 0.81 Inventory Turnover 1.25
Taxes Income Tax 54K Effective Tax Rate -0.09%
Stock Price Statistics The stock price has increased by -49.3% in the
last 52 weeks. The beta is 1.64, so AVITA Medical's
price volatility has been higher than the market average.
Beta 1.64 52-Week Price Change -49.3% 50-Day Moving Average 5.13 200-Day Moving Average 7.53 Relative Strength Index (RSI) 53.89 Average Volume (20 Days) 662,528
Income Statement In the last 12 months, AVITA Medical had revenue of 64.25M
and earned -61.84M
in profits. Earnings per share was -2.39.
Revenue 64.25M Gross Profit 55.16M Operating Income -56.59M Net Income -61.84M EBITDA -55.34M EBIT -56.43M Earnings Per Share (EPS) -2.39
Full Income Statement Balance Sheet The company has 14.05M in cash and 45.98M in
debt, giving a net cash position of -31.93M.
Cash & Cash Equivalents 14.05M Total Debt 45.98M Net Cash -31.93M Retained Earnings -359.81M Total Assets 58.13M Working Capital -26.35M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -48.94M
and capital expenditures -9.33M, giving a free cash flow of -58.27M.
Operating Cash Flow -48.94M Capital Expenditures -9.33M Free Cash Flow -58.27M FCF Per Share -2.25
Full Cash Flow Statement Margins Gross margin is 85.85%, with operating and profit margins of -88.08% and -96.26%.
Gross Margin 85.85% Operating Margin -88.08% Pretax Margin -96.17% Profit Margin -96.26% EBITDA Margin -86.13% EBIT Margin -88.08% FCF Margin -90.69%
Dividends & Yields RCEL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for RCEL is $13,
which is 137.7% higher than the current price. The consensus rating is "Buy".
Price Target $13 Price Target Difference 137.7% Analyst Consensus Buy Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 30, 2020. It was a
backward
split with a ratio of 1:5.
Last Split Date Jun 30, 2020 Split Type backward Split Ratio 1:5
Scores Altman Z-Score -9.79 Piotroski F-Score 3
